Adenovirus Vaccine Market - Global Outlook and Forecast 2022-2028

March 2022 | 78 pages | ID: A668D308159BEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Adenovirus Vaccine in global, including the following market information:

Global Adenovirus Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Adenovirus Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Adenovirus Vaccine companies in 2021 (%)

The global Adenovirus Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Type 4 Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Adenovirus Vaccine include Teva Pharmaceuticals and Barr Labs etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Adenovirus Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Adenovirus Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Adenovirus Vaccine Market Segment Percentages, by Type, 2021 (%)

• Type 4 Vaccine
• Type 7 Vaccine

Global Adenovirus Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Adenovirus Vaccine Market Segment Percentages, by Application, 2021 (%)

• Research & Academic Laboratories
• Pharmaceutical & Biotechnology Companies
• Others

Global Adenovirus Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Adenovirus Vaccine Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Adenovirus Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Adenovirus Vaccine revenues share in global market, 2021 (%)

Key companies Adenovirus Vaccine sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Adenovirus Vaccine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Teva Pharmaceuticals
• Barr Labs

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Adenovirus Vaccine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Adenovirus Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ADENOVIRUS VACCINE OVERALL MARKET SIZE

2.1 Global Adenovirus Vaccine Market Size: 2021 VS 2028
2.2 Global Adenovirus Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Adenovirus Vaccine Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Adenovirus Vaccine Players in Global Market
3.2 Top Global Adenovirus Vaccine Companies Ranked by Revenue
3.3 Global Adenovirus Vaccine Revenue by Companies
3.4 Global Adenovirus Vaccine Sales by Companies
3.5 Global Adenovirus Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Adenovirus Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Adenovirus Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Adenovirus Vaccine Players in Global Market
  3.8.1 List of Global Tier 1 Adenovirus Vaccine Companies
  3.8.2 List of Global Tier 2 and Tier 3 Adenovirus Vaccine Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Adenovirus Vaccine Market Size Markets, 2021 & 2028
  4.1.2 Type 4 Vaccine
  4.1.3 Type 7 Vaccine
4.2 By Type - Global Adenovirus Vaccine Revenue & Forecasts
  4.2.1 By Type - Global Adenovirus Vaccine Revenue, 2017-2022
  4.2.2 By Type - Global Adenovirus Vaccine Revenue, 2023-2028
  4.2.3 By Type - Global Adenovirus Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Adenovirus Vaccine Sales & Forecasts
  4.3.1 By Type - Global Adenovirus Vaccine Sales, 2017-2022
  4.3.2 By Type - Global Adenovirus Vaccine Sales, 2023-2028
  4.3.3 By Type - Global Adenovirus Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Adenovirus Vaccine Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Adenovirus Vaccine Market Size, 2021 & 2028
  5.1.2 Research & Academic Laboratories
  5.1.3 Pharmaceutical & Biotechnology Companies
  5.1.4 Others
5.2 By Application - Global Adenovirus Vaccine Revenue & Forecasts
  5.2.1 By Application - Global Adenovirus Vaccine Revenue, 2017-2022
  5.2.2 By Application - Global Adenovirus Vaccine Revenue, 2023-2028
  5.2.3 By Application - Global Adenovirus Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Adenovirus Vaccine Sales & Forecasts
  5.3.1 By Application - Global Adenovirus Vaccine Sales, 2017-2022
  5.3.2 By Application - Global Adenovirus Vaccine Sales, 2023-2028
  5.3.3 By Application - Global Adenovirus Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Adenovirus Vaccine Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Adenovirus Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Adenovirus Vaccine Revenue & Forecasts
  6.2.1 By Region - Global Adenovirus Vaccine Revenue, 2017-2022
  6.2.2 By Region - Global Adenovirus Vaccine Revenue, 2023-2028
  6.2.3 By Region - Global Adenovirus Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Adenovirus Vaccine Sales & Forecasts
  6.3.1 By Region - Global Adenovirus Vaccine Sales, 2017-2022
  6.3.2 By Region - Global Adenovirus Vaccine Sales, 2023-2028
  6.3.3 By Region - Global Adenovirus Vaccine Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Adenovirus Vaccine Revenue, 2017-2028
  6.4.2 By Country - North America Adenovirus Vaccine Sales, 2017-2028
  6.4.3 US Adenovirus Vaccine Market Size, 2017-2028
  6.4.4 Canada Adenovirus Vaccine Market Size, 2017-2028
  6.4.5 Mexico Adenovirus Vaccine Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Adenovirus Vaccine Revenue, 2017-2028
  6.5.2 By Country - Europe Adenovirus Vaccine Sales, 2017-2028
  6.5.3 Germany Adenovirus Vaccine Market Size, 2017-2028
  6.5.4 France Adenovirus Vaccine Market Size, 2017-2028
  6.5.5 U.K. Adenovirus Vaccine Market Size, 2017-2028
  6.5.6 Italy Adenovirus Vaccine Market Size, 2017-2028
  6.5.7 Russia Adenovirus Vaccine Market Size, 2017-2028
  6.5.8 Nordic Countries Adenovirus Vaccine Market Size, 2017-2028
  6.5.9 Benelux Adenovirus Vaccine Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Adenovirus Vaccine Revenue, 2017-2028
  6.6.2 By Region - Asia Adenovirus Vaccine Sales, 2017-2028
  6.6.3 China Adenovirus Vaccine Market Size, 2017-2028
  6.6.4 Japan Adenovirus Vaccine Market Size, 2017-2028
  6.6.5 South Korea Adenovirus Vaccine Market Size, 2017-2028
  6.6.6 Southeast Asia Adenovirus Vaccine Market Size, 2017-2028
  6.6.7 India Adenovirus Vaccine Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Adenovirus Vaccine Revenue, 2017-2028
  6.7.2 By Country - South America Adenovirus Vaccine Sales, 2017-2028
  6.7.3 Brazil Adenovirus Vaccine Market Size, 2017-2028
  6.7.4 Argentina Adenovirus Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Adenovirus Vaccine Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Adenovirus Vaccine Sales, 2017-2028
  6.8.3 Turkey Adenovirus Vaccine Market Size, 2017-2028
  6.8.4 Israel Adenovirus Vaccine Market Size, 2017-2028
  6.8.5 Saudi Arabia Adenovirus Vaccine Market Size, 2017-2028
  6.8.6 UAE Adenovirus Vaccine Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Teva Pharmaceuticals
  7.1.1 Teva Pharmaceuticals Corporate Summary
  7.1.2 Teva Pharmaceuticals Business Overview
  7.1.3 Teva Pharmaceuticals Adenovirus Vaccine Major Product Offerings
  7.1.4 Teva Pharmaceuticals Adenovirus Vaccine Sales and Revenue in Global (2017-2022)
  7.1.5 Teva Pharmaceuticals Key News
7.2 Barr Labs
  7.2.1 Barr Labs Corporate Summary
  7.2.2 Barr Labs Business Overview
  7.2.3 Barr Labs Adenovirus Vaccine Major Product Offerings
  7.2.4 Barr Labs Adenovirus Vaccine Sales and Revenue in Global (2017-2022)
  7.2.5 Barr Labs Key News

8 GLOBAL ADENOVIRUS VACCINE PRODUCTION CAPACITY, ANALYSIS

8.1 Global Adenovirus Vaccine Production Capacity, 2017-2028
8.2 Adenovirus Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Adenovirus Vaccine Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 ADENOVIRUS VACCINE SUPPLY CHAIN ANALYSIS

10.1 Adenovirus Vaccine Industry Value Chain
10.2 Adenovirus Vaccine Upstream Market
10.3 Adenovirus Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Adenovirus Vaccine Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Adenovirus Vaccine in Global Market
Table 2. Top Adenovirus Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Adenovirus Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Adenovirus Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Adenovirus Vaccine Sales by Companies, (K Units), 2017-2022
Table 6. Global Adenovirus Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Adenovirus Vaccine Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Adenovirus Vaccine Product Type
Table 9. List of Global Tier 1 Adenovirus Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Adenovirus Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Adenovirus Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Adenovirus Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Adenovirus Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Adenovirus Vaccine Sales (K Units), 2017-2022
Table 15. By Type - Global Adenovirus Vaccine Sales (K Units), 2023-2028
Table 16. By Application – Global Adenovirus Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Adenovirus Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Adenovirus Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Adenovirus Vaccine Sales (K Units), 2017-2022
Table 20. By Application - Global Adenovirus Vaccine Sales (K Units), 2023-2028
Table 21. By Region – Global Adenovirus Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Adenovirus Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Adenovirus Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Adenovirus Vaccine Sales (K Units), 2017-2022
Table 25. By Region - Global Adenovirus Vaccine Sales (K Units), 2023-2028
Table 26. By Country - North America Adenovirus Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Adenovirus Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Adenovirus Vaccine Sales, (K Units), 2017-2022
Table 29. By Country - North America Adenovirus Vaccine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Adenovirus Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Adenovirus Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Adenovirus Vaccine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Adenovirus Vaccine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Adenovirus Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Adenovirus Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Adenovirus Vaccine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Adenovirus Vaccine Sales, (K Units), 2023-2028
Table 38. By Country - South America Adenovirus Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Adenovirus Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Adenovirus Vaccine Sales, (K Units), 2017-2022
Table 41. By Country - South America Adenovirus Vaccine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Adenovirus Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Adenovirus Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Adenovirus Vaccine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Adenovirus Vaccine Sales, (K Units), 2023-2028
Table 46. Teva Pharmaceuticals Corporate Summary
Table 47. Teva Pharmaceuticals Adenovirus Vaccine Product Offerings
Table 48. Teva Pharmaceuticals Adenovirus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Barr Labs Corporate Summary
Table 50. Barr Labs Adenovirus Vaccine Product Offerings
Table 51. Barr Labs Adenovirus Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Adenovirus Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 53. Global Adenovirus Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 54. Global Adenovirus Vaccine Production by Region, 2017-2022 (K Units)
Table 55. Global Adenovirus Vaccine Production by Region, 2023-2028 (K Units)
Table 56. Adenovirus Vaccine Market Opportunities & Trends in Global Market
Table 57. Adenovirus Vaccine Market Drivers in Global Market
Table 58. Adenovirus Vaccine Market Restraints in Global Market
Table 59. Adenovirus Vaccine Raw Materials
Table 60. Adenovirus Vaccine Raw Materials Suppliers in Global Market
Table 61. Typical Adenovirus Vaccine Downstream
Table 62. Adenovirus Vaccine Downstream Clients in Global Market
Table 63. Adenovirus Vaccine Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Adenovirus Vaccine Segment by Type
Figure 2. Adenovirus Vaccine Segment by Application
Figure 3. Global Adenovirus Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Adenovirus Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Adenovirus Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Adenovirus Vaccine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Adenovirus Vaccine Revenue in 2021
Figure 9. By Type - Global Adenovirus Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Adenovirus Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Adenovirus Vaccine Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Adenovirus Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Adenovirus Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Adenovirus Vaccine Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Adenovirus Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Adenovirus Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Adenovirus Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Adenovirus Vaccine Sales Market Share, 2017-2028
Figure 19. US Adenovirus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Adenovirus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Adenovirus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Adenovirus Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Adenovirus Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Adenovirus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Adenovirus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Adenovirus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Adenovirus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Adenovirus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Adenovirus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Adenovirus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Adenovirus Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Adenovirus Vaccine Sales Market Share, 2017-2028
Figure 33. China Adenovirus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Adenovirus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Adenovirus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Adenovirus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Adenovirus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Adenovirus Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Adenovirus Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Adenovirus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Adenovirus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Adenovirus Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Adenovirus Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Adenovirus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Adenovirus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Adenovirus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Adenovirus Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Adenovirus Vaccine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Adenovirus Vaccine by Region, 2021 VS 2028
Figure 50. Adenovirus Vaccine Industry Value Chain
Figure 51. Marketing Channels